Everolimus attenuates glutamate-induced PC12 cells death

References

• Hu Y, Li J, Liu P, et al. Protection of SH-SY5Y neuronal cells from glutamate-induced apoptosis by 3,6’-disinapoyl sucrose, a bioactive compound isolated from Radix Polygala. J Biomed Biotechnol. 2012;2012:1–5.
   Google Scholar
• Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460(2):525–542.
   PubMed Web of Science ®Google Scholar
• Froissard P, Duval D. Cytotoxic effects of glutamic acid on PC12 cells. Neurochem Int. 1994;24(5):485–493.
   PubMed Web of Science ®Google Scholar
• Gerstner B, Lee J, DeSilva TM, et al. 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res. 2009;87(9):2078–2086.
   PubMed Web of Science ®Google Scholar
• Fasolo A, Sessa C. mTOR inhibitors in the treatment of cancer. Expert Opin Investig Drugs. 2008;17(11):1717–1734.
   PubMed Web of Science ®Google Scholar
• Lebwohl D, Anak Ö, Sahmoud T, et al. Development of everolimus, a novel oral mTOR inhibitor, across a spectrum of diseases. Ann N Y Acad Sci. 2013;1291:14–32.
   PubMed Web of Science ®Google Scholar
• Bockaert J, Marin P. mTOR in brain physiology and pathologies. Physiol Rev. 2015;95(4):1157–1187.
   PubMed Web of Science ®Google Scholar
• Lipton JO, Sahin M. The neurology of mTOR. Neuron. 2014;84(2):275–291.
   PubMed Web of Science ®Google Scholar
• McCabe MP, Cullen ER, Barrows CM, et al. Genetic inactivation of mTORC1 or mTORC2 in neurons reveals distinct functions in glutamatergic synaptic transmission. Elife. 2020;9:e51440–e51469.
   PubMed Web of Science ®Google Scholar
• Takei N, Nawa H. mTOR signaling and its roles in normal and abnormal brain development. Front Mol Neurosci. 2014;28–40.
   Google Scholar
• Aoki Y, Nakahara T, Asano D, et al. Preventive effects of rapamycin on inflammation and capillary degeneration in a rat model of NMDA-induced retinal injury. Biol Pharm Bull. 2015;38(2):321–324.
   PubMed Web of Science ®Google Scholar
• Erlich S, Alexandrovich A, Shohami E, et al. Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis. 2007;26(1):86–93.
   PubMed Web of Science ®Google Scholar
• Su W, Li Z, Jia Y, et al. Rapamycin is neuroprotective in a rat chronic hypertensive glaucoma model. PLoS One. 2014;9(6):e99719.
   PubMed Web of Science ®Google Scholar
• Huiras P, Gabardi S. Everolimus: a review of its pharmacologic properties and use in solid organ transplantation. Rev Health Care. 2011;2(4):229–241.
   Google Scholar
• Suvanish Kumar VS, Pretorius E, Rajanikant GK. The Synergistic Combination of Everolimus and Paroxetine Exerts Post-ischemic Neuroprotection In Vitro. Cell Mol Neurobiol. 2018;38(7):1383–1397.
   PubMed Web of Science ®Google Scholar
• Saliba SW, Vieira EL, Santos RP, et al. Neuroprotective effects of intrastriatal injection of rapamycin in a mouse model of excitotoxicity induced by quinolinic acid. J Neuroinflammation. 2017;14(1):25–37.
   PubMedGoogle Scholar
• Chauhan A, Sharma U, Jagannathan NR, et al. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav Brain Res. 2011;225(2):603–609.
   PubMed Web of Science ®Google Scholar
• Chen HC, Fong TH, Hsu PW, et al. Multifaceted effects of rapamycin on functional recovery after spinal cord injury in rats through autophagy promotion, anti-inflammation, and neuroprotection. J Surg Res. 2013;179(1):e203-210–e210.
   Web of Science ®Google Scholar
• Bove J, Martinez-Vicente M, Vila M. Fighting neurodegeneration with rapamycin: mechanistic insights. Nat Rev Neurosci. 2011;12(8):437–452.
   PubMed Web of Science ®Google Scholar
• Dai C, Ciccotosto GD, Cappai R, et al. Rapamycin Confers Neuroprotection against Colistin-Induced Oxidative Stress, Mitochondria Dysfunction, and Apoptosis through the Activation of Autophagy and mTOR/Akt/CREB Signaling Pathways. ACS Chem Neurosci. 2018;9(4):824–837.
   PubMed Web of Science ®Google Scholar
• Hayashi I, Aoki Y, Asano D, et al. Protective Effects of Everolimus against N-Methyl-D-aspartic Acid-Induced Retinal Damage in Rats. Biol Pharm Bull. 2015;38(11):1765–1771.
   PubMed Web of Science ®Google Scholar
• Ichikawa A, Nakahara T, Kurauchi Y, et al. Rapamycin prevents N-methyl-D-aspartate-induced retinal damage through an ERK-dependent mechanism in rats. J Neurosci Res. 2014;92(6):692–702.
   PubMed Web of Science ®Google Scholar
• Fanoudi S, Hosseini M, Alavi MS, et al. Everolimus, a mammalian target of rapamycin inhibitor, ameliorated streptozotocin-induced learning and memory deficits via neurochemical alterations in male rats. Excli J. 2018;17:999–1017.
   PubMed Web of Science ®Google Scholar
• Sadowski K, Kotulska-Jóźwiak K, Jóźwiak S. Role of mTOR inhibitors in epilepsy treatment. Pharmacol Rep. 2015;67(3):636–646.
   PubMed Web of Science ®Google Scholar
• Yang M-T, Lin Y-C, Ho W-H, et al. Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures. J Neuroinflammation. 2017;14(1):15–25.
   PubMedGoogle Scholar
• Gorshtein A, Rubinfeld H, Kendler E, et al. Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocr Relat Cancer. 2009;16(3):1017–1027.
   PubMed Web of Science ®Google Scholar
• Witzig TE, Reeder C, Han JJ, et al. The mTORC1 inhibitor everolimus has anti-tumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma. Blood: blood. 2015;126(3):328–335. ) 2015-2002-629543
   PubMed Web of Science ®Google Scholar
• Hosseini A, Shafiee-Nick R, Mousavi SH. Combination of Nigella sativa with Glycyrrhiza glabra and Zingiber officinale augments their protective effects on doxorubicin-induced toxicity in h9c2 cells. Iran J Basic Med Sci. 2014;17(12):993–1000.
   PubMed Web of Science ®Google Scholar
• Yu W, Sheng M, Xu R, et al. Berberine protects human renal proximal tubular cells from hypoxia/reoxygenation injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways. J Transl Med. 2013;11(1):25–35.
   PubMedGoogle Scholar
• Ghorbani A, Sadeghnia HR, Asadpour E. Mechanism of protective effect of lettuce against glucose/serum deprivation-induced neurotoxicity. Nutr Neurosci. 2015;18(3):103–109.
   PubMed Web of Science ®Google Scholar
• Rajabian A, Boroushaki MT, Hayatdavoudi P, et al. Boswellia serrata Protects Against Glutamate-Induced Oxidative Stress and Apoptosis in PC12 and N2a Cells. DNA Cell Biol. 2016;35(11):666–679.
   PubMed Web of Science ®Google Scholar
• Wang C-J, Hu C-P, Xu K-P, et al. Protective effect of selaginellin on glutamate-induced cytotoxicity and apoptosis in differentiated PC12 cells. Naunyn Schmiedebergs Arch Pharmacol. 2010;381(1):73–81.
   PubMed Web of Science ®Google Scholar
• Li N, Liu B, Dluzen DE, et al. Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J Ethnopharmacol. 2007;111(3):458–463.
   PubMed Web of Science ®Google Scholar
• Penugonda S, Mare S, Goldstein G, et al. Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12. Brain Res. 2005;1056(2):132–138.
   PubMed Web of Science ®Google Scholar
• Sadeghnia HR, Rajabian A, Ghorbani A, et al. Effects of standardized extract of Ferula gummosa root on glutamate-induced neurotoxicity. Folia Neuropathol. 2017;55(4):340–346.
   PubMed Web of Science ®Google Scholar
• Tan JW, Tham CL, Israf DA, et al. Neuroprotective effects of biochanin A against glutamate-induced cytotoxicity in PC12 cells via apoptosis inhibition. Neurochem Res. 2013;38(3):512–518.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang W, Hao C, et al. Astaxanthin protects PC12 cells from glutamate-induced neurotoxicity through multiple signaling pathways. J Funct Foods. 2015;16:137–151.
   Web of Science ®Google Scholar
• Zhao H, Yenari MA, Cheng D, et al. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity. J Neurochem. 2003;85(4):1026–1036.
   PubMed Web of Science ®Google Scholar
• Song Y, Xue H, Liu T, et al. Rapamycin plays a neuroprotective effect after spinal cord injury via anti-inflammatory effects. J Biochem Mol Toxicol. 2015;29(1):29–34.
   PubMed Web of Science ®Google Scholar
• Malagelada C, Jin ZH, Jackson-Lewis V, et al. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson’s disease. J Neurosci. 2010;30(3):1166–1175.
   PubMed Web of Science ®Google Scholar
• Yin L, Ye S, Chen Z, et al. Rapamycin preconditioning attenuates transient focal cerebral ischemia/reperfusion injury in mice. Int J Neurosci. 2012;122(12):748–756.
   PubMed Web of Science ®Google Scholar
• Caccamo A, Majumder S, Deng JJ, et al. Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J Biol Chem. 2009;284(40):27416–27424.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mejia ME, Morales M, Hernandez-Kelly LC, et al. Glutamate-dependent translational regulation in cultured Bergmann glia cells: involvement of p70S6K. Neuroscience. 2006;141(3):1389–1398.
   PubMed Web of Science ®Google Scholar
• Magnuson B, Ekim B, Fingar DC. Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J. 2012;441(1):1–21.
   PubMed Web of Science ®Google Scholar
• Zepeda RC, Barrera I, Castelan F, et al. Glutamate-dependent phosphorylation of the mammalian target of rapamycin (mTOR) in Bergmann glial cells. Neurochem Int. 2009;55(5):282–287.
   PubMed Web of Science ®Google Scholar
• Kimura R, Okouchi M, Fujioka H, et al. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience. 2009;162(4):1212–1219.
   PubMed Web of Science ®Google Scholar
• Gong R, Park CS, Abbassi NR, et al. Roles of glutamate receptors and the mammalian target of rapamycin (mTOR) signaling pathway in activity-dependent dendritic protein synthesis in hippocampal neurons. J Biol Chem. 2006;281(27):18802–18815.
   PubMed Web of Science ®Google Scholar
• Ryskalin L, Lazzeri G, Flaibani M, et al. 2017. mTOR-dependent cell proliferation in the brain. 2017
   Google Scholar
• Jiang Q, Gu Z, Zhang G, et al. Diphosphorylation and involvement of extracellular signal-regulated kinases (ERK1/2) in glutamate-induced apoptotic-like death in cultured rat cortical neurons. Brain Res. 2000;857(1-2):71–77.
   PubMed Web of Science ®Google Scholar
• Molz S, Dal‐Cim T, Budni J, et al. Neuroprotective effect of guanosine against glutamate-induced cell death in rat hippocampal slices is mediated by the phosphatidylinositol-3 kinase/Akt/ glycogen synthase kinase 3β pathway activation and inducible nitric oxide synthase inhibition . J Neurosci Res. 2011;89(9):1400–1408.
   PubMed Web of Science ®Google Scholar
• Pi R, Li W, Lee NT, et al. Minocycline prevents glutamate‐induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways. J Neurochem. 2004;91(5):1219–1230.
   PubMed Web of Science ®Google Scholar
• Szydlowska K, Gozdz A, Dabrowski M, et al. Prolonged activation of ERK triggers glutamate-induced apoptosis of astrocytes: neuroprotective effect of FK506 . J Neurochem. 2010;113(4):904–918.
   PubMed Web of Science ®Google Scholar
• Abd-Elrahman KS, Ferguson S. Modulation of mTOR and CREB pathways following mGluR5 blockade contribute to improved Huntington’s pathology in zQ 175 mice. 2019; 12: 1–9
   Google Scholar
• Zhang C, Yuan X-r, Li H-y, et al. Anti-cancer effect of metabotropic glutamate receptor 1 inhibition in human glioma U87 cells: involvement of PI3K/Akt/mTOR pathway. Cell Physiol Biochem. 2015;35(2):419–432.
   PubMedGoogle Scholar
• Zhu M, Qin YC, Gao CQ, et al. Extracellular Glutamate-Induced mTORC1 Activation via the IR/IRS/PI3K/Akt Pathway Enhances the Expansion of Porcine Intestinal Stem Cells. J Agric Food Chem. 2019;67(34):9510–9521.
   PubMed Web of Science ®Google Scholar
• Li X-G, Sui W-G, Gao C-Q, et al. L-Glutamate deficiency can trigger proliferation inhibition via down regulation of the mTOR/S6K1 pathway in pig intestinal epithelial cells. 2016;94:1541–1549.
   Google Scholar
• Ye J-l, Gao C-q, Li X-g, et al. EAAT3 promotes amino acid transport and proliferation of porcine intestinal epithelial cells. Oncotarget. 2016;7(25):38681–38692.
   PubMedGoogle Scholar
• Swiatkowski P, Nikolaeva I, Kumar G, et al. Role of Akt-independent mTORC1 and GSK3β signaling in sublethal NMDA-induced injury and the recovery of neuronal electrophysiology and survival. Sci Rep. 2017;7(1):1539–1554.
   PubMedGoogle Scholar
• Li X, Wu C, Chen N, et al. PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma. Oncotarget. 2016;7(22):33440–33450.
   PubMedGoogle Scholar
• Morrison R, Kinoshita Y. The role of p53 in neuronal cell death. Cell Death Differ. 2000;7(10):868–879.
   PubMed Web of Science ®Google Scholar
• Qin Z-H, Chen R-W, Wang Y, et al. Nuclear factor κB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum. J Neurosci. 1999;19(10):4023–4033.
   PubMed Web of Science ®Google Scholar
• Xiang H, Hochman DW, Saya H, et al. Evidence for p53-mediated modulation of neuronal viability. J Neurosci. 1996;16(21):6753–6765.
   PubMed Web of Science ®Google Scholar
• Castedo M, Ferri KF, Blanco J, et al. Human Immunodeficiency Virus 1 Envelope Glycoprotein Complex-induced Apoptosis Involves Mammalian Target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation . J Exp Med. 2001;194(8):1097–1110.
   PubMed Web of Science ®Google Scholar
• Ding K, Wang H, Wu Y, et al. Rapamycin protects against apoptotic neuronal death and improves neurologic function after traumatic brain injury in mice via modulation of the mTOR-p53-Bax axis. J Surg Res. 2015;194(1):239–247.
   PubMed Web of Science ®Google Scholar
• Jiang J, Jiang J, Zuo Y, et al. Rapamycin protects the mitochondria against oxidative stress and apoptosis in a rat model of Parkinson’s disease. Int J Mol Med. 2013;31(4):825–832.
   PubMed Web of Science ®Google Scholar
• Demerlé-Pallardy C, Lonchampt M-O, Chabrier P-E, et al. Nitric oxide synthase induction in glial cells: effect on neuronal survival. Life Sci. 1993;52(23):1883–1890.
   PubMed Web of Science ®Google Scholar
• Dello Russo C, Lisi L, Tringali G, et al. Involvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferation. Biochem Pharmacol. 2009;78(9):1242–1251.
   PubMed Web of Science ®Google Scholar
• Lisi L, Navarra P, Feinstein DL, et al. The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. J Neuroinflammation. 2011;8(1):1–11.
   PubMedGoogle Scholar
• Fox JH, Connor T, Chopra V, et al. The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington’s disease. Mol Neurodegener. 2010;5:26–37.
   PubMed Web of Science ®Google Scholar